BeOne Medicines Ltd. (ONC) operating KPIs
ONCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BEIGF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/302313% above fair value
$370.33−1.23 (-0.33%)
Close on Oct 30, 2026Market cap $42.11BP/E 66.2Yield –
Latest, FY2025
4,227
Period ended Dec 31, 2025
Change on a year earlier
+11.7%
3,784 in FY2024
History
12 years
Since FY2014
Sources
8
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Total operating expenses ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 4,227 | +11.7% | Form 10-K (filed 2026-02-26) ↗ |
| FY2024 | Dec 31, 2024 | 3,784 | +15.1% | Form 10-K (filed 2025-02-27) ↗ |
| FY2023 | Dec 31, 2023 | 3,287 | +12.6% | Form 10-K (filed 2024-02-26) ↗ |
| FY2022 | Dec 31, 2022 | 2,919 | +19.1% | Form 10-K (filed 2024-02-26) ↗ |
| FY2021 | Dec 31, 2021 | 2,450 | +24.6% | Form 10-K (filed 2024-02-26) ↗ |
| FY2020 | Dec 31, 2020 | 1,967 | +41.7% | Form 10-K (filed 2021-02-25) ↗ |
| FY2019 | Dec 31, 2019 | 1,388 | +53.6% | Form 10-K (filed 2020-03-02) ↗ |
| FY2018 | Dec 31, 2018 | 904 | +168.4% | Form 10-K (filed 2019-02-28) ↗ |
| FY2017 | Dec 31, 2017 | 337 | +185.2% | Form 10-K (filed 2018-02-28) ↗ |
| FY2016 | Dec 31, 2016 | 118 | +80.0% | Form 10-K (filed 2017-03-22) ↗ |
| FY2015 | Dec 31, 2015 | 65.6 | +127.8% | Form 10-K (filed 2017-03-22) ↗ |
| FY2014 | Dec 31, 2014 | 28.8 | – | Form 10-K (filed 2017-03-22) ↗ |
Cite this data
StockData. (2026). BeOne Medicines Total operating expenses ($M) ($M), annual FY2014–FY2025 [Data set]. Compiled from BeOne Medicines SEC filings and investor materials. https://stockdatahq.com/stocks/onc/kpis/fs_tot_opex
See every metric in the BeOne Medicines KPI table. Data updated Oct 29, 2026.